GGrantIndex
← Leaderboards

Chu Chen

Fred Hutchinson Cancer Research Center

$16,558,917
Attributed
$16,558,917
Total exposure
7
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2M · FY200521
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$16,558,917 · 7

By mechanism

R01$13,826,478 · 5
U01$2,294,697 · 1
R21$437,742 · 1

Top collaborators

No co-investigators on record.

Most similar at Fred Hutchinson Cancer Research Center

Same institution · by research overlap

Others in their field

Top investigators on “Sampling

Research focus

SamplingTumorCessation Of LifeMalignant NeoplasmsGenesEnrollmentWashingtonBaseDiagnosisParticipantCharacteristicsOperative Surgical ProceduresTumor TissueMolecularFollow-UpCancer RiskPersonsLeadResourcesStagingGenotypeInvestigationGene ExpressionWoman

Grant awards (28)

Infrastructure Support and Pilot Tissue Collection for the CARET Biorepository$592,642
U01 · FY2021 · CA · contact PI
Infrastructure Support and Pilot Tissue Collection for the CARET Biorepository$590,562
U01 · FY2020 · CA · contact PI
Infrastructure Support and Pilot Tissue Collection for the CARET Biorepository$546,507
U01 · FY2019 · CA · contact PI
Infrastructure Support and Pilot Tissue Collection for the CARET Biorepository$564,986
U01 · FY2018 · CA · contact PI
FFPE Validation of a Survival Gene Signature in HPV-Negative Oral Cavity Cancer$612,024
R01 · FY2017 · CA · contact PI
FFPE Validation of a Survival Gene Signature in HPV-Negative Oral Cavity Cancer$678,016
R01 · FY2016 · CA · contact PI
Salivary Metabolite Biomarkers for Diagnosing Nodal Metastasis in Oral Cancer$190,343
R21 · FY2016 · CA · contact PI
FFPE Validation of a Survival Gene Signature in HPV-Negative Oral Cavity Cancer$723,600
R01 · FY2015 · CA · contact PI
Salivary Metabolite Biomarkers for Diagnosing Nodal Metastasis in Oral Cancer$247,399
R21 · FY2015 · CA · contact PI
Oral Cancer: Molecular Profiles & Clinical Outcomes$976,944
R01 · FY2010 · CA · contact PI
MOLECULAR EPIDEMIOLOGY OF LUNG CANCER$386,463
R01 · FY2010 · CA · contact PI
Oral Cancer: Molecular Profiles & Clinical Outcomes$966,967
R01 · FY2009 · CA · contact PI
MOLECULAR EPIDEMIOLOGY OF LUNG CANCER$165,522
R01 · FY2009 · CA · contact PI
MOLECULAR EPIDEMIOLOGY OF LUNG CANCER$514,881
R01 · FY2008 · CA · contact PI
ORAL CANCER: MOLECULAR PROFILES & CLINICAL OUTCOMES$902,972
R01 · FY2007 · CA · contact PI
MOLECULAR EPIDEMIOLOGY OF LUNG CANCER$537,172
R01 · FY2007 · CA · contact PI
Molecular Epidemiology of Endometrial Cancer$277,765
R01 · FY2007 · CA · contact PI
ORAL CANCER: MOLECULAR PROFILES & CLINICAL OUTCOMES$803,646
R01 · FY2006 · CA · contact PI
Molecular Epidemiology of Endometrial Cancer$631,839
R01 · FY2006 · CA · contact PI
MOLECULAR EPIDEMIOLOGY OF LUNG CANCER$566,492
R01 · FY2006 · CA · contact PI
ORAL CANCER: MOLECULAR PROFILES &CLINICAL OUTCOMES$798,521
R01 · FY2005 · CA
Molecular Epidemiology of Endometrial Cancer$622,295
R01 · FY2005 · CA
ORAL CANCER: MOLECULAR PROFILES &CLINICAL OUTCOMES$791,172
R01 · FY2004 · CA
Molecular Epidemiology of Endometrial Cancer$629,145
R01 · FY2004 · CA
ORAL CANCER: MOLECULAR PROFILES &CLINICAL OUTCOMES$831,653
R01 · FY2003 · CA
BREAST CANCER AND GENE POLYMORPHISMS IN CHINESE WOMEN$563,596
R01 · FY2003 · CA
BREAST CANCER AND GENE POLYMORPHISMS IN CHINESE WOMEN$432,773
R01 · FY2002 · CA
BREAST CANCER AND GENE POLYMORPHISMS IN CHINESE WOMEN$413,020
R01 · FY2001 · CA